Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.41 |
| ▸ | ECE1 | P42892 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | MDM4 | O15151 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1409212 | 0.99 | PTGS1 (0.46) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL8431345 | 0.97 | PTGS1 (0.45) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL8135287 | 0.97 | PTGS1 (0.45) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL9225749 | 0.96 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL17479582 | 0.96 | PTGS1 (0.46) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL1443581 | 0.96 | PTGS1 (0.46) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL8503980 | 0.96 | PTGS1 (0.46) | PTGS1GSTK1GLO1ECE1OPRD1 | |
| SCHEMBL17479694 | 0.95 | PTGS1 (0.48) | PTGS1GSTK1GLO1MEN1KMT2A | |
| SCHEMBL153301 | 0.95 | PTGS1 (0.48) | PTGS1GSTK1GLO1MEN1KMT2A | |
| SCHEMBL8045766 | 0.94 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1PDCD1LG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111770996-B | Mutant beta-glucosidase | 花王株式会社 | 2024-03-26 | — | — | CN | disclosed |
| CN-113956327-B | Polypeptide targeting human APC protein and application thereof in preparation of medicines | 中山大学肿瘤防治中心 | 2024-01-30 | — | — | CN | disclosed |
| WO-2023219160-A1 | NOVEL CELLULAR IMMUNE-POTENTIATING ADJUVANT | 日本ビーシージー製造株式会社 | 2023-11-16 | — | — | WO | disclosed |
| CN-111757939-B | Mutant beta-glucosidase | 花王株式会社 | 2023-11-07 | — | — | CN | disclosed |
| CN-116802197-A | Pharmaceutical composition for preventing or treating tuberculosis | 格纳西尼有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-115989412-A | Rapid and simple antibody detection using covalently immobilized self-assembled polypeptides | 西西欧艾(杭州)生物医药有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115956090-A | Immobilized self-assembling protein multimers | 西西欧艾(杭州)生物医药有限责任公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-108350475-B | Steviol glycoside using AOBGL1 homologue and method for producing steviol | 三得利控股株式会社 | 2022-12-13 | — | — | CN | disclosed |
| CN-115279789-A | Antibodies that disrupt the interaction of GAL3 and insulin receptor or integrin and methods of use thereof | 真和制药有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-108138198-B | Microorganisms engineered for improved yield | 合成基因组股份有限公司 | 2022-10-28 | — | — | CN | disclosed |
| WO-1998005347-A1 | COMPOUNDS THAT INHIBIT INTERACTION BETWEEN SIGNAL-TRANSDUCING PROTEINS AND THE GLGF (PDZ/DHR) DOMAIN AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0822980-A1 | RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF | SYNTRO CORPORATION (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1998004702-A2 | PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF HELICOBACTER PYLORI, THEIR PREPARATION AND USE | CHIRON BEHRING GMBH & CO. (DE) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997009428-A9 | COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS | — | 1997-05-15 | — | — | WO | disclosed |
| WO-1997009429-A2 | COMPOUNDS AND METHODS FOR DIAGNOSIS OF TUBERCULOSIS | CORIXA CORPORATION (US) | 1997-03-13 | — | — | WO | disclosed |
| WO-1996029396-A1 | RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF | SYNTRO CORPORATION (US) | 1996-09-26 | — | — | WO | disclosed |
| EP-0663010-A1 | METHODS FOR INCREASING SECRETION OF OVEREXPRESSED PROTEINS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994008012-A1 | METHODS FOR INCREASING SECRETION OF OVEREXPRESSED PROTEINS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| EP-0569527-A1 | INHERITED AND SOMATIC MUTATIONS OF APC GENE IN COLORECTAL CANCER OF HUMANS | THE JOHNS HOPKINS UNIVERSITY (US) | 1993-11-18 | — | — | EP | disclosed |
| WO-1992013103-A1 | INHERITED AND SOMATIC MUTATIONS OF APC GENE IN COLORECTAL CANCER OF HUMANS | THE JOHNS HOPKINS UNIVERSITY (US) | 1992-08-06 | — | — | WO | disclosed |